Brief: Cvi Investments Inc. Reports 9.9% Passive Stake In Theriva Biologics Inc.
Oct 2 (Reuters) - Theriva Biologics Inc TOVX.A :
* CVI INVESTMENTS, INC. REPORTS 9.9% PASSIVE STAKE IN
THERIVA
BIOLOGICS, INC. AS OF SEPT 27 - SEC FILING
Further company coverage: TOVX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theriva Biologics
See all newsTheriva Biologics Q2 net loss narrows on lower R&D costs, expenses
Brief: Theriva™ Biologics Announces Upcoming Presentation Of Additional Data From The Virage Phase 2B Clinical Trial Of Vcn-01 In Metastatic Pancreatic Cancer At Aacr 2026 Annual Meeting
Brief: Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications
Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
Brief: Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025